According to Dr. Reddy's Laboratories's latest financial reports and stock price the company's current number of shares outstanding is 833,313,679. At the end of 2024 the company had 833,313,679 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 0.83 B | 0.08% |
2023 | 0.83 B | 0.27% |
2022 | 0.83 B | 0.1% |
2021 | 0.82 B | -0.28% |
2020 | 0.83 B | 0.38% |
2019 | 0.82 B | -0.08% |
2018 | 0.82 B | 0% |
2017 | 0.82 B | 0.14% |
2016 | 0.82 B | -2.91% |
2015 | 0.85 B | 0.14% |
2014 | 0.85 B | 0.16% |
2013 | 0.85 B | 0.16% |
2012 | 0.84 B | 0.17% |
2011 | 0.84 B | 0.19% |
2010 | 0.84 B | 0.25% |
2009 | 0.84 B | 0.24% |
2008 | 0.84 B | 0.17% |
2007 | 0.84 B | 5.43% |
2006 | 0.79 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | 5,675,000,000 | 581.02% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | 1,138,000,000 | 36.56% | ๐ฎ๐ฑ Israel |
![]() GlaxoSmithKline GSK | 2,038,500,000 | 144.63% | ๐ฌ๐ง UK |
![]() Novartis NVS | 1,968,000,000 | 136.17% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | 2,467,800,000 | 196.14% | ๐ซ๐ท France |